Italy Artificial Organs & Bionic Implants Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Italy Artificial Organs & Bionic Implants Market is Segmented By Type (Artificial Organs, and Bionics). The report offers the value (in USD million) for the above segments.

Italy Artificial Organs & Bionic Implants Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Italy Artificial Organs & Bionic Implants Market Size

Italy Artificial Organs & Bionic Implants Market Summary
Study Period 2019 - 2030
Base Year For Estimation 2024
Forecast Data Period 2025 - 2030
Historical Data Period 2019 - 2023
CAGR 2.00 %
Market Concentration Medium

Major Players

Italy Artificial Organs & Bionic Implants Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Italy Artificial Organs & Bionic Implants Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Italy Artificial Organs & Bionic Implants Market Analysis

The Italy Artificial Organs & Bionic Implants Market is expected to register a CAGR of 2% during the forecast period.

The initial stages of the COVID-19 pandemic significantly impacted the Italy artificial organs & bionic implants market. For instance, according to an article published by the National Library of Medicine, in July 2022, during the first four weeks of the COVID-19 pandemic in Italy, there was a 25% reduction in the total organ procured. Less availability of ICU beds for both transplant recipients and donors negatively impacted total donation activity and ultimately resulted in fewer transplants. This led to a reduction in demand for artificial organs & bionic implants. However, most countries, including Italy, adopted vaccination prioritization processes, including priority for solid organ transplantation recipients to reduce the infection risk. For instance, according to the above source, transplantation rates returned to pre-pandemic levels, novel treatments were identified, and vaccination of solid organ transplantation recipients was prioritized. Approximately 80% of solid organ transplantation recipients in Italy received at least a vaccine dose by October 2021. Thus, with an increased initiative for the safety of solid organ transplantation recipients, the market started to witness a pre-pandemic level growth rate gradually.

The major factors driving the market growth are increased incidence of disabilities, organ failures and scarcity of donors, high road accidents leading to amputations, and technological advancements in artificial organs and bionics. For instance, in the article published by Istat on Road accidents in Italy, the number of accidents per 100 thousand inhabitants was higher than the national average (256.9) in 7 regions (from 473.6 in Liguria to 259.1 in Lombardy region), lower in Calabria (139.6), Molise (143.9) and Campania ( 160.7) in 2021. Thus, the high burden of road accidents in the country is expected to increase the chances of amputation, thereby fuelling the growth of the market studied over the forecast period.

Furthermore, strategic initiatives by key players such as various product development, mergers, acquisitions, and collaboration are likely to accelerate market growth. For instance, in September 2022, Pixium Vision SA announced the report of the completion of patient enrollment in the PRIMAvera pivotal trial in atrophic dry age-related macular degeneration (dry AMD), also known as Geographic Atrophy. The study was initiated in Q4 2020 in France, where the first patient was enrolled in December 2020. Pixium Vision has since established additional clinical sites and implanted patients in France, Germany, the UK, the Netherlands, and Italy. Such development is expected to drive the growth of the market in Italy over the forecast period.

However, expensive procedures and the risk of compatibility issues and malfunctions are expected to restrain the market growth.

Italy Artificial Organs & Bionic Implants Industry Overview

The Italy artificial organs & bionic implants market is moderately competitive in nature due to the presence of companies operating in Italy. Some of the companies currently operating in the market are Abiomed Inc., LivaNova, PLC., Cochlear Ltd, Berlin Heart, and Medtronic, among others.

Italy Artificial Organs & Bionic Implants Market Leaders

  1. Cochlear Ltd

  2. Abiomed Inc.

  3. Berlin Heart

  4. Össur

  5. LivaNova, PLC

  6. *Disclaimer: Major Players sorted in no particular order
Italy Artificial Organs & Bionic Implants Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

Italy Artificial Organs & Bionic Implants Market News

  • In February 2023, Pixium Vision SA received a cash position of EUR 7.7 million in December 2022, providing an estimated cash runway through the end of Q2 2023. The increased cash outflow was primarily due to the enrolment and implantation of patients with the PRIMAvera pivotal trial for atrophic dry age-related macular degeneration (dry AMD) in Italy.
  • In September 2022, the Alliance for Paired Kidney Donation launched a pilot program that would allow kidney exchanges for transplantation between the United States and Italy. The signing of the agreement between the Alliance for Paired Kidney Donation (APKD) and Centro Nazionali Trapianti (CNT), the organization which manages all transplantation activity in Italy allows for the first-ever exchange of living donor kidneys between Europe and the U.S.

Italy Artificial Organs & Bionic Implants Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increased Incidence of Disabilities, Organ Failures and Scarcity of Donors
    • 4.2.2 High Incidence of Road Accidents Leading to Amputations
    • 4.2.3 Technological Advancements in the Artificial Organ and Bionics
  • 4.3 Market Restraints
    • 4.3.1 Expensive Procedures
    • 4.3.2 Risk of Compatibility Issues and Malfunctions
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - USD Million)

  • 5.1 By Type
    • 5.1.1 Artificial Organ
    • 5.1.1.1 Artificial Heart
    • 5.1.1.2 Artificial Kidney
    • 5.1.1.3 Cochlear Implants
    • 5.1.1.4 Other Organ Types
    • 5.1.2 Bionics
    • 5.1.2.1 Ear Bionics
    • 5.1.2.2 Orthopedic Bionic
    • 5.1.2.3 Cardiac Bionics
    • 5.1.2.4 Eye Bionics
    • 5.1.2.5 Others

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abiomed Inc.
    • 6.1.2 Cochlear Ltd
    • 6.1.3 Berlin Heart
    • 6.1.4 Medtronic
    • 6.1.5 Esko Bionics
    • 6.1.6 Össur
    • 6.1.7 LivaNova, PLC
    • 6.1.8 Getinge AB
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Italy Artificial Organs & Bionic Implants Industry Segmentation

As per the scope of the report, artificial organs are mechanical devices that can temporarily or permanently substitute for a body organ. Artificial Organs are implemented in human bodies with living tissue, which can perform the original function of human body parts. Bionics refers to the replacement or improvement of body parts by mechanical kinds. The Italy Artificial Organs & Bionic Implants Market is Segmented By Type (Artificial Organs (Artificial Heart, Artificial Kidney, Cochlear Implants, and Other Organ Types), and Bionics(Ear Bionics, Orthopedic Bionic, Cardiac Bionics, Eye Bionics and Others)). The report offers the value (in USD million) for the above segments.

By Type Artificial Organ Artificial Heart
Artificial Kidney
Cochlear Implants
Other Organ Types
Bionics Ear Bionics
Orthopedic Bionic
Cardiac Bionics
Eye Bionics
Others
Need A Different Region or Segment?
Customize Now

Italy Artificial Organs & Bionic Implants Market Research FAQs

What is the current Italy Artificial Organs & Bionic Implants Market size?

The Italy Artificial Organs & Bionic Implants Market is projected to register a CAGR of 2% during the forecast period (2025-2030)

Who are the key players in Italy Artificial Organs & Bionic Implants Market?

Cochlear Ltd, Abiomed Inc., Berlin Heart, Össur and LivaNova, PLC are the major companies operating in the Italy Artificial Organs & Bionic Implants Market.

What years does this Italy Artificial Organs & Bionic Implants Market cover?

The report covers the Italy Artificial Organs & Bionic Implants Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Italy Artificial Organs & Bionic Implants Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Italy Artificial Organs & Bionic Implants Industry Report

Statistics for the 2025 Italy Artificial Organs & Bionic Implants market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Italy Artificial Organs & Bionic Implants analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.

Italy Artificial Organs & Bionic Implants Market Report Snapshots